Global Stem Cells
Verita Neuro (DBA of Global Stem Cells) is a Singapore-based medical tourism company that facilitates advanced neuromodulation and regenerative treatments for international patients with spinal cord injuries and neurological conditions across hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.
- Company typePrivate
- Founded2015
- HeadquartersSingapore, Singapore, Singapore
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Global Stem Cells does
Global Stem Cells, doing business as Verita Neuro, is a Singapore-incorporated private medical tourism company that facilitates advanced neurological and spinal cord injury treatments for international patients. The company operates a direct-to-consumer model in which prospective patients initiate contact through a free consultation and are then coordinated through dedicated Patient Representatives to treatment delivery at partner hospitals across Thailand, Mexico, Canada, UAE, and Ukraine.
Its treatment portfolio centers on neuromodulation and regenerative medicine, including Epidural Stimulation (electrical stimulation of the spinal cord to encourage restoration of voluntary movement), Brain Stimulation for stroke and traumatic brain injury recovery, LamiSpine (a proprietary surgical procedure combining spinal decompression with stem cell injection), Stem Cell Therapy for neurological and autoimmune conditions, Vagus Nerve Stimulation, and the ReWalk robotic exoskeleton. The company claims to be the first in the world to offer Epidural Stimulation and markets proprietary treatment protocols as competitive differentiators.
Revenue is generated on a per-procedure basis, with pricing determined through individual consultation rather than publicly disclosed. In 2025, the company reported treating 99 patients from 30 countries and delivering 44 Epidural Stimulation surgeries, 71 Stem Cell treatments, and 11 LamiSpine surgeries, alongside 4,983 hours of mapping, 4,075 hours of physical therapy, and 667 hours of occupational therapy. The company maintains a small internal team of five named medical professionals, with treatment delivery executed through trusted international hospital partnerships including Fakeeh University Hospital in Dubai and the Unbroken National Rehabilitation Center in Ukraine.
Global Stem Cells firmographics
Firmographics- Name
- Global Stem Cells
- Legal name
- Verita Neuro Pte Ltd
- Website
- https://globalstemcells.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Verita Neuro (DBA of Global Stem Cells) is a Singapore-based medical tourism company that facilitates advanced neuromodulation and regenerative treatments for international patients with spinal cord injuries and neurological conditions across hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.
- Ownership category
- akta.pro rank
Global Stem Cells industry classification
Industry- Product category
- Neurological Treatment Services
- NAICS
- Nursing Care Facilities (Skilled Nursing Facilities) (623110)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurorehabilitation Centers (HLAFAFAH)
- akta.pro secondary industry
- Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)
Keywords
Where Global Stem Cells is headquartered
LocationHeadquarters
- HQ city
- Singapore, Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices5 records
Markets served
Global Stem Cells business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Medical Treatment Services: Revenue is generated through the provision of neurological and spinal cord injury treatments to international patients across its treatment center network. Treatments include epidural stimulation surgery, stem cell therapy, LamiSpine surgery, brain stimulation, vagus nerve stimulation, and rehabilitation programs including the ReWalk exoskeleton. The company operates on a per-procedure/per-treatment basis facilitated through its international hospital partnerships.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels10 records
Global Stem Cells product offering
Product offeringCore offering
Verita Neuro is a medical tourism and treatment facilitation company that delivers advanced neurorestorative treatments to international patients with spinal cord injuries, stroke, brain injuries, and other neurological conditions. Its service portfolio includes epidural stimulation, brain stimulation, LamiSpine surgery, stem cell therapy, vagus nerve stimulation, and ReWalk exoskeleton gait training. Treatments are coordinated through dedicated Patient Representatives and delivered via partnerships with international hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.
Product overview
Verita Neuro is a neurorestorative medical treatment company offering a portfolio of advanced neurological and spinal cord injury treatments. The company pioneered Epidural Stimulation and has developed breakthrough treatments including LamiSpine (combining spinal decompression with stem cell injection), Brain Stimulation, and Stem Cell treatments. Their neuromodulation and regenerative treatments are delivered across treatment centers in Thailand (flagship), Mexico, Canada, UAE, and Ukraine (opening 2026). Treatments include Epidural Stimulation for voluntary movement restoration, Brain Stimulation for stroke/brain injury recovery, LamiSpine for combined surgical and regenerative care, Stem Cell treatments for neurological and autoimmune conditions, Vagus Nerve Stimulation for minimally invasive neuromodulation, and ReWalk Exoskeleton for robotic-assisted mobility. The company reports 99 patients treated from 30 countries in 2025, completing 44 epidural stimulation surgeries, 71 stem cell treatments, and 11 LamiSpine surgeries.
Differentiator
Problem solved
Functional benefit
Products and services
- Epidural Stimulation Neurorestorative treatment that reconnects pathways between the brain and body through electrical stimulation of the spinal cord, encouraging restoration of voluntary movement in spinal cord injury patients.
- Brain Stimulation Neuromodulation treatment targeting stroke and brain injury recovery, aiming to encourage restoration of movement and speech.
- LamiSpine Proprietary surgical procedure combining spinal decompression with stem cell injection for neurorestorative outcomes in spinal cord treatment.
- Stem Cell Treatment Regenerative treatment utilizing stem cells to help restore function and reduce inflammation in neurological and autoimmune conditions.
- Vagus Nerve Stimulation Minimally invasive neuromodulation treatment for stroke and traumatic brain injury recovery.
- ReWalk Exoskeleton Robotic exoskeleton suitable for paraplegic spinal cord injury patients, enabling walking and stair climbing at home and in everyday life as part of rehabilitation programs.
Quantifiable outcome
- Voluntary movement restoration in spinal cord injury patients
- +6 more outcomes
Companies that use Global Stem Cells
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Global Stem Cells technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Global Stem Cells partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Unbroken National Rehabilitation Center (Ukraine)flagshipVerita Neuro signed a landmark agreement with the Unbroken National Rehabilitation Center in Lviv, Ukraine to launch a pioneering spinal cord injury treatment center. Opening in 2026, this will be Verita Neuro's first treatment center in Europe, providing neurorestorative care to patients in Ukraine. The partnership was announced on July 7, 2026, and represents a significant strategic expansion into the European market.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Global Stem Cells competitors and assessment
Company assessmentDirect peers
- Regenexx: US-based regenerative medicine network offering stem cell and platelet-based treatments for orthopedic and neurological conditions through a clinic franchise model. Comparable in regenerative treatment philosophy, though more US-domestic and clinically conservative.
- Unique Access Medical: Singapore-headquartered medical tourism facilitator offering advanced stem cell and regenerative therapies for neurological and chronic conditions to international patients. Closely mirrors Verita Neuro's Singapore-base, multi-country facilitator model with hospital-based delivery.
- Infusio: Germany-headquartered regenerative medicine provider offering stem cell and immune-modulating therapies for chronic and neurological conditions to an international patient base. Comparable medical-tourism, multi-modality regenerative approach.
- Swiss Medica: Switzerland- and Serbia-based stem cell therapy clinic serving international patients with neurological, autoimmune, and degenerative conditions. Comparable in medical-tourism facilitation model, treatment menu, and out-of-pocket international patient focus.
- Beike Biotechnology: China-based stem cell processing and treatment provider operating internationally for neurological, orthopedic, and autoimmune conditions. Comparable as a global stem cell therapy provider targeting cross-border patients.
- GIOSTAR (Global Institute of Stem Cell Therapy & Research): Global stem cell therapy provider operating hospital-based treatment centers across multiple countries (Mexico, India, UAE, US) targeting neurological, orthopedic, and autoimmune conditions. Directly comparable as a multi-jurisdiction regenerative medicine medical tourism operator.
- Stemaid Institute: Mexico-based regenerative medicine clinic offering stem cell therapies for neurological and autoimmune conditions to international patients. Comparable medical-tourism, hospital-based, multi-condition stem cell model.
Others
- Ekso Bionics: Developer of robotic exoskeletons for rehabilitation and spinal cord injury patients. Comparable as a technology supplier in the SCI mobility ecosystem overlapping with Verita Neuro's ReWalk offering.
- ReWalk Robotics: Developer of the ReWalk exoskeleton, which Verita Neuro actively prescribes and fits to SCI patients. Related as an enabling technology supplier and ecosystem participant rather than a direct treatment competitor.
Emerging players
- ONWARD Medical: Clinical-stage company developing epidural stimulation and brain-computer interface technologies for spinal cord injury. Directly comparable on the epidural stimulation technology front but as a research-driven medtech rather than a treatment facilitator.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Global Stem Cells social profiles
Digital presenceGlobal Stem Cells financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Stem Cells leadership team
Management profileNumber of profiles
Profiles5 records
Global Stem Cells funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Stem Cells M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Stem Cells
What does Global Stem Cells do?
Verita Neuro is a medical tourism and treatment facilitation company that delivers advanced neurorestorative treatments to international patients with spinal cord injuries, stroke, brain injuries, and other neurological conditions. Its service portfolio includes epidural stimulation, brain stimulation, LamiSpine surgery, stem cell therapy, vagus nerve stimulation, and ReWalk exoskeleton gait training. Treatments are coordinated through dedicated Patient Representatives and delivered via partnerships with international hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.
Is Global Stem Cells a public or private company?
Global Stem Cells is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Global Stem Cells founded?
Global Stem Cells was founded in 2015. It employs 1 to 10 people.
Where is Global Stem Cells based?
Global Stem Cells is headquartered in Singapore, Singapore, Singapore, in the Asia region.
How does Global Stem Cells make money?
One revenue line is on record: medical Treatment Services.
Who are Global Stem Cells's main competitors?
Direct peers on record are Regenexx, Unique Access Medical, Infusio, Swiss Medica, Beike Biotechnology, GIOSTAR (Global Institute of Stem Cell Therapy & Research) and Stemaid Institute. Others are Ekso Bionics and ReWalk Robotics. ONWARD Medical is listed as an emerging player.
Does Global Stem Cells have an API?
No public API is recorded for Global Stem Cells.
What industry is Global Stem Cells in?
Global Stem Cells's product category is Neurological Treatment Services. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s). Its NAICS code is 623110 and its SIC code is 8000.